NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biopharmaceutical’

13 April 2015

TVM Capital reveals Hong Kong expansion amid China biopharma fund close

life science test tube_sq Venture capital investor TVM Capital Life Science has hit a $50m first close for its first biopharma fund exclusively focused on expanding Western businesses to the Chinese market.

4 March 2015

OrbiMed leads weighty $30m round in biopharmaceutical company Tricida

download (65) Venture capital firm OrbiMed has led a $30m Series B financing round in San Francisco-based biopharmaceutical company Tricida.

3 March 2015

Rock Springs, Sofinnova in cool $70m Series E for biopharma company Chiasma

syringe-m Venture capital investors Rock Springs Capital and Sofinnova Ventures have taken part in a sizable $70m funding round for US biopharmaceutical Chiasma.

23 February 2015

VC-backed Heptares Therapeutics sold to Japanese trade partner for $400m

sold-sale-exit-deal UK biopharmaceutical Heptares Therapeutics, whose backers have included MVM Life Science Partners, Novartis Venture Fund and Takeda Ventures, has been sold to Tokyo-listed pharma company Sosei Group Corporation.

28 January 2015

VC-backed Zosano Pharma launches IPO

Pharmedium drugs Venture capital-backed biopharmaceutical company Zosano Pharma has launched for an Intial public offering, pricing its 4.5 million shares at $11 per share.

2 January 2015

Aperture reels in nearly $50m for third health-care fund

health healthcare drugs pills medication medical New York-based investor Aperture Venture Partners has reeled in nearly half of its $100m target for its third fund health-care fund, AltAssets can reveal.

22 October 2014

Brandon Point, Woodford in Series D round for biopharmaceutical

fungus-3-1411424-m UK fund manager Woodford Investment Management and Brandon Point Industries have provided $60m Series D financing for antifungal research company Viamet Pharmaceuticals Holdings.

14 October 2014

Cancer, virus treatment business Rigontec nets €9.45m VC-backed Series A

cells5_sq Wellington Partners and Boehringer Ingelheim Venture Fund have co-led a €9.45m Series A financing round for cancer and virus-focused biopharma business Rigontec.

26 August 2014

Sofinnova, Rock Springs in $55m Series C for Parkinson’s relief pharma company

luxurary-74895-m Sofinnova Ventures, Rock Springs Capital and Adage Capital Management are among new investors in a sizable $55m funding round for biopharmaceutical company Civitas Therapeutics.

5 August 2014

Healthcare Royalty Partners pulls in more than $1bn for Fund III $

crown royalty Global investment firm Healthcare Royalty Partners has gathered more than $1bn towards its latest vehicle targeting innovative biopharmaceutical businesses in Europe, the US and Asia.

Page 1 of 612345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015